In addition to the intrinsic mechanisms that may allow DTC to escape immune detection as described above, tumor cells may also actively render cytotoxic T-cells less effective via secretion of TGF-β, a factor that is also secreted by or released from mineralized bone by activated osteoclasts. This evidence concerns the gene TGFB1 and neoplasm.